Intravitreal bevacizumab for macular oedema secondary to branch retinal vein occlusion

被引：0
|
作者：
K Gündüz
S J Bakri
机构：
[1] Mayo Clinic,Department of Ophthalmology
来源：
Eye | 2008年 / 22卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1168 / 1171
页数：3
相关论文
共 50 条
  • [31] Intravitreal bevacizumab in macular edema secondary to branch retinal vein occlusion: 12-month results
    Thapa, Raba
    Maharjan, Nhukesh
    Paudyal, Govinda
    CLINICAL OPHTHALMOLOGY, 2012, 6 : 1057 - 1062
  • [32] Comparison of Natural Course, Intravitreal Triamcinolone, and Intravitreal Bevacizumab for Treatment of Macular Edema Secondary to Branch Retinal Vein Occlusion
    Kwon, Soon Il
    Kim, Young Wook
    Bang, Ye Won
    Lee, Joo Yeon
    Park, In Won
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2013, 29 (01) : 5 - 9
  • [33] Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective study
    Kriechbaum, K.
    Michels, S.
    Prager, F.
    Georgopoulos, M.
    Funk, M.
    Geitzenauer, W.
    Schmidt-Erfurth, U.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2008, 92 (04) : 518 - 522
  • [34] Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizumab
    T D Papakostas
    L Lim
    T van Zyl
    J B Miller
    B S Modjtahedi
    C M Andreoli
    D Wu
    L H Young
    I K Kim
    D G Vavvas
    D D Esmaili
    D Husain
    D Eliott
    L A Kim
    Eye, 2016, 30 : 79 - 84
  • [35] Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizumab
    Papakostas, T. D.
    Lim, L.
    van Zyl, T.
    Miller, J. B.
    Modjtahedi, B. S.
    Andreoli, C. M.
    Wu, D.
    Young, L. H.
    Kim, I. K.
    Vavvas, D. G.
    Esmaili, D. D.
    Husain, D.
    Eliott, D.
    Kim, L. A.
    EYE, 2016, 30 (01) : 79 - 84
  • [36] REBOUND OF MACULAR EDEMA AFTER INTRAVITREAL BEVACIZUMAB THERAPY IN EYES WITH MACULAR EDEMA SECONDARY TO BRANCH RETINAL VEIN OCCLUSION
    Yasuda, Shunsuke
    Kondo, Mineo
    Kachi, Shu
    Ito, Yasuki
    Terui, Takayuki
    Ueno, Shinji
    Terasaki, Hiroko
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2011, 31 (06): : 1075 - 1082
  • [37] Rebound of Macular Edema After Intravitreal Bevacizumab Therapy in Eyes With Macular Edema Secondary to Branch Retinal Vein Occlusion
    Yasuda, S.
    Kondo, M.
    Kachi, S.
    Ito, Y.
    Terui, T.
    Terasaki, H.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [38] Comparison of immediate versus deferred intravitreal Bevacizumab in macular oedema due to branch retinal vein occlusion: a pilot study
    M. A. Khan
    Varakutti Mallika
    Dattakiran Joshi
    International Ophthalmology, 2018, 38 : 943 - 949
  • [39] Comparison of immediate versus deferred intravitreal Bevacizumab in macular oedema due to branch retinal vein occlusion: a pilot study
    Khan, M. A.
    Mallika, Varakutti
    Joshi, Dattakiran
    INTERNATIONAL OPHTHALMOLOGY, 2018, 38 (03) : 943 - 949
  • [40] Intravitreal triamcinolone acetonide for ischaemic macular oedema caused by branch retinal vein occlusion
    Chen, SDM
    Lochhead, J
    Patel, CK
    Frith, P
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2004, 88 (01) : 154 - 155
12345